Traws Pharma Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
6.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
0.00
|
-8.81
|
0.00
|
0.00%
|
|
2024-06-30
|
0.00
|
-4.87
|
0.00
|
0.00%
|
|
2024-03-31
|
-0.23
|
-0.19
|
0.04
|
17.39%
|
|
2023-12-31
|
-0.25
|
-0.19
|
0.06
|
24.00%
|
|
2023-09-30
|
-0.29
|
-0.23
|
0.06
|
20.69%
|
|
2023-06-30
|
-0.31
|
-0.20
|
0.11
|
35.48%
|
|
2023-03-31
|
-0.30
|
-0.28
|
0.02
|
6.67%
|
|
2022-12-31
|
0.00
|
-6.48
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-13.87
|
|
2023-12-31
|
-0.90
|
|
2022-12-31
|
-22.67
|
|
2021-12-31
|
-24.67
|
|
2020-12-31
|
-54.17
|
|
2019-12-31
|
-1008.29
|
|
2018-12-31
|
-3031.28
|
|
2017-12-31
|
-15811.80
|
|
2016-12-31
|
-32141.29
|
|
2015-12-31
|
-62771.40
|
|
2014-12-31
|
-165477.83
|
|
2013-12-31
|
-406955.03
|